Summary
The treatment of Sprague-Dawley rats with monoamine oxidase (MAO) inhibitors (pargyline, tranylcypromine) profoundly affects dopamine (DA) and norepinephrine (NE) metabolism in the brain. In these rats injection of L-dopa led to large increases in norepinephrine (NE), normetanephrine (NMN) and 3-methoxytyramine (3-MT) in brain tissues. The response of MAO-inhibited rats to L-dopa contrasted sharply with those not treated with the MAO inhibitor; the latter showed no change in NE, NMN and 3-MT after similar administration of L-dopa. The increase of NE in pargyline-treated rats correlated closely with that of DA in the hypothalamus and in the brain stem. This response was greatly diminished in rats previously treated with the neurotoxin 6-hydroxydopamine, but was restored when the treatment with 6-hydroxydopamine was accompanied by desimipramine. This suggests that noradrenergic neurons were the origin of the NE response. The NMN and 3-MT increases occurring only in the rats treated with a MAO inhibitor were highly correlated. The results suggested that MAO inhibitor may affect entry of DA into catecholaminergic storage where NE synthesis takes place and from where DA is released.
Similar content being viewed by others
References
Buu NT (1985 a) Dopamine sulfoconjugation in the rat brain: regulation by monoamine oxidase. J Neurochem 45: 470–476
Buu NT (1985 b) Relationship between catechol-O-methyltransferase and phenolsulfotransferase in the metabolism of dopamine in the rat brain. J Neurochem 45: 1612–1619
Buu NT, Duhaime J, Kuchel O, Genest J (1981) The convulsive effects of dopamine sulfate conjugates in rat brain. Life Sci 29: 2311–2316
Buu NT, Duhaime J, Kuchel O (1985) Effect of L-dopa on the concentrations of free and sulfoconjugated catecholamines in plasma, cerebrospinal fluid, urine, and central and peripheral nervous system tissues of the rat. J Neurochem 44: 787–792
Callahan MF, Beales M, Oltmans G, Berenbaum SA, Meyers PE, Pullen G, Hansen T (1982) Blood pressure and locomotor activity in spontaneously hypertensive rats (SHR's) after 6-OH DA treatment. Soc Neurosci Abst 8: 428
Carlsson A, Hillarp NE (1962) Formation of phenolic acid in brain after administration of 3,4-dihydroxyphenylalanine. Acta Physiol Scand 55: 95–100
Chalmers JP, Baldessarini RJ, Wurtman RJ (1971) Effects of L-dopa on norepinephrine metabolism in the brain. Proc Natl Acad Sci USA 68: 662–666
Commissiong JW (1984) Synthesis of catecholamines in the developing spinal cord of the rat. J Neurochem 42: 1574–1581
Doshi P, Edwards DJ (1981) Effects of L-dopa on dopamine and norepinephrine concentrations in the rat brain assessed by gas chromatography. J Chromatogr 210: 505–511
Edwards DJ, Rizk M (1981) Conversion of 3, 4-dihydroxyphenylalanine and deuterated 3, 4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain. J Neurochem 36: 1641–1647
Fletscher A (1966) Monoamine oxidase inhibitors. Pharmacol Rev 18: 121–129
Foldes A, Meek JL (1974) Occurrence and localization of brain phenol-sulfotransferase. J Neurochem 23: 303–307
Freed CR, Murphy RC (1978) Mass spectrometric measurement of catecholamine turnover in rat hypothalamus after long-term L-dopa infusion. J Pharmacol Exp Ther 205: 702–709
Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H] norepinephrine, [3H] dopamine, and [3H] dopa in various regions of the brain. J Neurochem 13: 655–699
Green AR, Youdim MBH (1975) Effects of monoamine oxidase inhibition by clorgyline, deprenyl, or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. BrJ Pharmacol 55: 415–422
Kehr W (1981) 3-methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo. J Neural Transm 50: 165–178
Renskers KJ, Feor KD, Roth JA (1980) Sulfation of dopamine and other biogenic amines by human brain phenolsulfotransferase. J Neurochem 34: 1362–1368
Westerink BHC (1984) Determination of normetanephrine, 3, 4-dihydroxy-phenylethyleneglycol (free and total), and 3-methoxy-4-hydroxyphenylethyleneglycol (free and total) in rat brain by high performance liquid chromatography with electrochemical detection and effects of drugs on regional concentrations. J Neurochem 42: 934–942
Westerink BHC, Spaan SJ (1982) Estimation of the turnover of 3-methoxytyramine in the rat striatum by HPLC with electrochemical detection: implications for the sequence in the cerebral metabolism of dopamine. J Neurochem 38: 342–347
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buu, N.T., Angers, M., Duhaime, J. et al. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors. J. Neural Transmission 70, 39–50 (1987). https://doi.org/10.1007/BF01252507
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01252507